Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M332Revenue (TTM) $M20.2Net Margin (%)-152.3Altman Z-Score-0.9
Enterprise Value $M214EPS (TTM) $-0.7Operating Margin %-157.2Piotroski F-Score5
P/E(ttm)--Beneish M-Score17.1Pre-tax Margin (%)-152.3Higher ROA y-yY
Price/Book7.210-y EBITDA Growth Rate %--Quick Ratio2.8Cash flow > EarningsY
Price/Sales16.35-y EBITDA Growth Rate %38.5Current Ratio2.8Lower Leverage y-yY
Price/Free Cash Flow4.2y-y EBITDA Growth Rate %--ROA % (ttm)-23.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-56.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M48.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CCXI

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CCXI is held by these investors:



CCXI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LUCAS ROGER CDirector 2017-05-01Sell4,000$7.31-5.61view
LUCAS ROGER CDirector 2017-02-01Sell4,000$7.32-5.74view
Cappel Markus J.Chief Bus. Officer & Treasurer 2017-01-03Sell26,821$7.51-8.12view
Bekker PetrusChief Medical Officer 2016-12-16Sell8,712$8.74-21.05view
Bekker PetrusChief Medical Officer 2016-12-05Sell30,000$8.5-18.82view
Bekker PetrusChief Medical Officer 2016-11-22Sell1,250$8.3-16.87view
Bekker PetrusChief Medical Officer 2016-11-11Sell33,332$8-13.75view
LUCAS ROGER CDirector 2016-11-01Sell4,000$6.113.11view
LUCAS ROGER CDirector 2016-09-01Sell4,000$5.0736.09view
Tyree James LDirector 2016-05-23Sell5,544$4.3957.18view

Press Releases about CCXI :

Quarterly/Annual Reports about CCXI:

News about CCXI:

Articles On GuruFocus.com
ChemoCentryx to Present at Two Upcoming Investor Conferences May 24 2017 
ChemoCentryx Granted EU Orphan Drug Designation for Avacopan in the Treatment of Debilitating Kidney May 23 2017 
ChemoCentryx Reports First Quarter 2017 Financial Results May 10 2017 
ChemoCentryx to Hold First Quarter 2017 Financial Results Conference Call on Wednesday, May 10, 2017 Apr 27 2017 
ChemoCentryx Receives FDA Orphan Drug Designation for Avacopan in the Treatment of Debilitating Kidn Mar 22 2017 
ChemoCentryx Reports Fourth Quarter and Full Year 2016 Financial Results Mar 14 2017 
ChemoCentryx to Hold Fourth Quarter 2016 Financial Results Conference Call on Tuesday, March 14, 201 Mar 01 2017 
Immune Design Insider Buys Shares Oct 03 2016 
Three Attractively Priced Small Cap Biotech Stocks Nov 05 2014 

More From Other Websites
ChemoCentryx to Present at Two Upcoming Investor Conferences May 24 2017
ChemoCentryx Granted EU Orphan Drug Designation for Avacopan in the Treatment of Debilitating Kidney... May 23 2017
Edited Transcript of CCXI earnings conference call or presentation 10-May-17 9:00pm GMT May 16 2017
ChemoCentryx, Inc. – Value Analysis (NASDAQ:CCXI) : May 15, 2017 May 15 2017
ChemoCentryx, Inc. breached its 50 day moving average in a Bullish Manner : CCXI-US : May 12, 2017 May 12 2017
ChemoCentryx reports 1Q loss May 10 2017
ChemoCentryx Reports First Quarter 2017 Financial Results May 10 2017
Investor Network: Chemocentryx, Inc. to Host Earnings Call May 10 2017
ChemoCentryx to Hold First Quarter 2017 Financial Results Conference Call on Wednesday, May 10, 2017 Apr 27 2017
ChemoCentryx, Inc. breached its 50 day moving average in a Bearish Manner : CCXI-US : April 6, 2017 Apr 06 2017
ChemoCentryx Receives FDA Orphan Drug Designation for Avacopan in the Treatment of Debilitating... Mar 22 2017
ChemoCentryx (CCXI) Shares March Higher, Can It Continue? Mar 17 2017
Edited Transcript of CCXI earnings conference call or presentation 14-Mar-17 9:00pm GMT Mar 15 2017
ChemoCentryx Reports Fourth Quarter and Full Year 2016 Financial Results Mar 14 2017
Biotech Premarket Movers: ChemoCentryx, Jazz, Ionis, Zogenix Mar 10 2017
Sio Capital Remains Bullish On These Stocks Despite Weak Performance Mar 03 2017
ChemoCentryx to Hold Fourth Quarter 2016 Financial Results Conference Call on Tuesday, March 14,... Mar 01 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)